Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-22

Clinical Trial Update: Management of Popeye Sign With Botulinum Toxin After Bicepstenotomy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the management of Popeye sign using botulinum toxin after biceps tenotomy is ongoing with undisclosed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: AZ Delta | Conditions: Popeye Syndrome | Phase 4 | Status: UNKNOWN